(-0.04%) 5 211.75 points
(-0.04%) 39 011 points
(-0.06%) 18 189 points
(-0.54%) $77.96
(0.23%) $2.21
(0.14%) $2 327.50
(0.33%) $27.64
(0.01%) $988.50
(0.18%) $0.931
(0.44%) $10.95
(0.20%) $0.801
(-0.02%) $91.43
-0.69% $ 7.96
Live Chart Being Loaded With Signals
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland...
Stats | |
---|---|
Volumen de hoy | 336 952 |
Volumen promedio | 2.33M |
Capitalización de mercado | 875.15M |
EPS | $0 ( 2024-03-25 ) |
Próxima fecha de ganancias | ( $-0.320 ) 2024-05-23 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.20 |
ATR14 | $0.0160 (0.20%) |
Volumen Correlación
Mesoblast Limited Correlación
10 Correlaciones Más Positivas | |
---|---|
PFSW | 0.949 |
LABP | 0.944 |
DSGN | 0.941 |
NN | 0.94 |
CTIC | 0.936 |
PRVB | 0.93 |
CDXC | 0.927 |
PESI | 0.927 |
IDN | 0.92 |
SCTL | 0.919 |
10 Correlaciones Más Negativas | |
---|---|
LIAN | -0.939 |
SBNYP | -0.928 |
LUCD | -0.923 |
LUNA | -0.922 |
NOVN | -0.912 |
NLSP | -0.909 |
AEY | -0.908 |
PRFT | -0.908 |
AZ | -0.907 |
EZGO | -0.905 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Mesoblast Limited Correlación - Moneda/Commodity
Mesoblast Limited Finanzas
Annual | 2023 |
Ingresos: | $7.50M |
Beneficio Bruto: | $-20.23M (-269.72 %) |
EPS: | $-1.050 |
FY | 2023 |
Ingresos: | $7.50M |
Beneficio Bruto: | $-20.23M (-269.72 %) |
EPS: | $-1.050 |
FY | 2022 |
Ingresos: | $10.21M |
Beneficio Bruto: | $-20.55M (-201.21 %) |
EPS: | $-1.330 |
FY | 2021 |
Ingresos: | $7.46M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.817 |
Financial Reports:
No articles found.
Mesoblast Limited
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company's products under the Phase III clinical trials include remestemcel-L for the treatment of steroid refractory acute graft versus host disease, as well as acute respiratory distress syndrome due to COVID-19 infection; Rexlemestrocel-L to treat advanced chronic heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV for the treatment of biologic refractory rheumatoid arthritis diabetic nephropathy. The company has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. for the treatment of wound healing in patients with epidermolysis bullosa; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico